Abstract
The majority of moisturizing creams on the market are regulated as cosmetics. However, moisturizing creams may also be classified as pharmaceuticals (equivalent to medicinal products) or as medical devices within the European Member States. During recent years, there has been an increase in topically applied semi-solid formulations certified as medical devices.
The regulatory demands and the approval process differ between the three regulatory categories. The present chapter gives a brief overview of the differences and similarities between the categories, where the topics such as efficacy, safety, labeling, manufacturing, vigilance, post-marketing surveillance, qualified and responsible persons are addressed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Korting HC, Schollmann C (2012) Medical devices in dermatology: topical semi-solid formulations for the treatment of skin diseases. J Dtsch Dermatol Ges 10:103–109
Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products (1976) OJ L 262/169. Non-official consolidated version at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1976L0768:20100301:en:PDF. Accessed May 2011
Buzek J, Ask B (2009) Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. Official Journal of the European Union, L342/59–L342/209
Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (2001) OJ L 311/67 as amended. Non-official consolidated version at: http://ec.europa.eu/health/documents/eudralex/vol-1/index_en.htm. Accessed May 2011
Council Directive 93/42/EEC concerning medical devices (1993) OJ L 169/1 as amended. Non-official consolidated version at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1993L0042:20071011:en:PDF. Accessed May 2011
CLP, Regulation (EC) 1272/2008 of the European Parliament and of the Council on classification, labeling and packaging of substances and mixtures (2008) OJ L 353/1 as amended. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:353:0001:1355:en:PDF. Accessed May 2011
Guidance document on the demarcation between the cosmetic products directive 76/768 and the medicinal products directive 2001/83 as agreed between the commission services and the competent authorities of member states. http://ec.europa.eu/consumers/sectors/cosmetics/files/doc/guidance_doc_cosm-medicinal_en.pdf. Accessed Feb 2012
MEDICAL DEVICES (2010) Guidance document. Borderline products, drug-delivery products and medical devices incorporating, as an integral part, an ancillary medicinal substance or an ancillary human blood derivative. Guidelines relating to the application of: the council directive 90/385/EEC on active implantable medical devices the council directive 93/42/EEC on medical devices. MEDDEV 2. 1/3 rev 3. http://ec.europa.eu/consumers/sectors/medical-devices/files/meddev/2_1_3_rev_3-12_2009_en.pdf. Accessed Feb 2012
MHRA (2011) Bulletin no. 17. Medical devices and medicinal products. http://www.mhra.gov.uk/home/groups/es-era/documents/publication/con007498.pdf. Accessed Sept 2011
de Groot AC (1990) Labelling cosmetics with their ingredients. BMJ 300(6740):1636–1638
MEDDEV 2.10–2 Rev. 1. Designation and monitoring of notified bodies within the framework of EC directives on medical devices. http://ec.europa.eu/health/medical-devices/files/meddev/2_10_2date04_2001_en.pdf. Accessed Sept 2011
Gardiner J et al. (2006) International sun protection factor (SPF) test method. Colipa Guideline www.cosmeticseurope.eu/downloads/86.html. Accessed Feb 2012
Verheugen G (2006) Commission recommendation of 22 September 2006 on the efficacy of sunscreen products and the claims made relating thereto. Off J Eur Union 265:265/39–265/43
SCCS (2010) The SCCS’s notes of guidance for the testing of cosmetic ingredients and their safety evaluation, 7th revision. http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_s_004.pdf. Accessed Feb 2012
Medical devices – application of risk management to medical devices. ISO 14971:2007. http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=38193. Accessed Sept 2011
WHO (2002) Safety of medicines – a guide to detecting and reporting adverse drug reactions - why health professionals need to take action. http://apps.who.int/medicinedocs/en/d/Jh2992e/. Accessed Feb 2012
MEDDEV 2.12–1 rev 6 (2009) Guidelines on a medical devices vigilance system. http://ec.europa.eu/health/medical-devices/files/meddev/2_12_1-rev_6–12–2009_en.pdf. Accessed Sept 2011
Guidelines. Medicinal products for human use. Safety, environment and information. Excipients in the label and package leaflet of medicinal products for human use, in Notice to applicants, E.C.E. directorate-general, Editor. 2003
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sörensen, A., Landvall, P., Lodén, M. (2012). Moisturizers as Cosmetics, Medicines, or Medical Device? The Regulatory Demands in the European Union. In: Lodén, M., Maibach, H. (eds) Treatment of Dry Skin Syndrome. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27606-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-27606-4_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-27605-7
Online ISBN: 978-3-642-27606-4
eBook Packages: MedicineMedicine (R0)